FDA Advisory Committee Recommends Approval of Regeneron and Sanofi's Praluent® (alirocumab) Injection for Patients with Hypercholesterolemia
Go back to FDA Advisory Committee Recommends Approval of Regeneron and Sanofi's Praluent® (alirocumab) Injection for Patients with Hypercholesterolemia| Regeneron (NASDAQ: REGN) | Delayed: 799.08 -11.23 (1.39%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $810.31 | 52 Week High | $592.36 | |||
| Open | $803.83 | 52 Week Low | $325.35 | |||
| Day High | $808.63 | P/E | 209.73 | |||
| Day Low | $796.73 | EPS | $3.81 | |||
| Volume | 97,227 | |||||
| BANCO SANTANDER S.A. (NYSE: SAN) | Delayed: 14.65 -0.21 (1.41%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $14.86 | 52 Week High | $5.58 | |||
| Open | $14.59 | 52 Week Low | $3.60 | |||
| Day High | $14.67 | P/E | N/A | |||
| Day Low | $14.54 | EPS | $0.00 | |||
| Volume | 2,064,744 | |||||
| SANOFI (NASDAQ: SNY) | Delayed: 43.07 -0.08 (0.19%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $43.15 | 52 Week High | $44.76 | |||
| Open | $43.08 | 52 Week Low | $36.81 | |||
| Day High | $43.46 | P/E | N/A | |||
| Day Low | $43.02 | EPS | $0.00 | |||
| Volume | 298,467 | |||||
